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endovascular aneurysm repair in high-risk patients
Dominique Fabre, MD, Elie Fadel, PhD, Philippe Brenot, MD,
Sarah Hamdi, MD, Abel Gomez Caro, MD, Sacha Mussot,
MD, Jean-Pierre Becquemin, MD, and Claude Angel, MD
Objective: This study evaluated endoleak level and size
decrease of infrarenal abdominal aortic aneurysm (AAA)
after endovascular aneurysm repair (EVAR) with coil
embolization in patients at high risk for type II endoleak.
Methods: Between 2009 and 2013, 83 of 187 patients (44.3%)
who underwent EVAR for AAA also underwent coil emboliza-
tion of the aneurysm sac immediately after complete stent
graft release because of risk factors for type II endoleak,
including absence of a circumferential thrombus, two or more
pairs of patent lumbar arteries, or a patent inferior mesenteric
artery. Coil embolizationwas achieved using a 4F catheter with
a microcatheter placed between the stent graft and the
aneurysm wall. Computed tomography and color duplex
ultrasound imaging were performed 1, 6, 12, and 24 months
later to look for an endoleakandassessaneurysmsacdiameter.
Results: Mean follow-up was 24  11 months (range, 6-53
months). A mean of 12 coils (range, 4-23) was used. Technical
success was achieved in all patients, with no procedurally
related complications. Follow-up computed tomography
showed type II endoleak in one patient. Aneurysm sac diameter
was signiﬁcantlydecreasedafter 6months (P= .001), 12months
(P= .001), and24months (P= .001). Surgerywas required inone
patient for common femoral artery occlusion unrelated to the
procedure and in another patient for distal type I endoleak.
Conclusions: Aneurysm sac coil embolization during EVAR
for patients at risk for type II endoleak is technically fea-
sible, safe, and effective in preventing type II endoleak. This
procedure leads to rapid AAA shrinkage. Thus, coil emboli-
zation could be used routinely to improve EVAR outcomes
for patients at risk for type II endoleak.Morbidity and mortality after use of iliac conduits for
endovascular aortic aneurysm repair
Prateek K. Gupta, MD, Abhishek Sundaram, MD, and K.
Craig Kent, MD*Full articles available online at www.jvascsurg.org
1078-5884/
http://dx.doi.org/10.1016/S1078-5884(15)00365-2Objective: Although placement of an open iliac conduit for
endovascular aortic aneurysm repair (EVAR) is generally felt
to result in higher morbidity and mortality, published lit-
erature is scarce. Our objective was to assess 30-day out-
comes after elective EVAR with an open iliac conduit using a
multi-institutional database.
Methods: Patients who underwent elective EVAR (n = 14,339)
for abdominal aortic aneurysm were identiﬁed from the
American College of Surgeons National Surgical Quality
Improvement Program 2005 to 2011 database. Univariable
andmultivariable logistic regression analyseswere performed.
Results: An open iliac conduit was used in 231 patients (1.6%),
and the remainder had femoral exposure or percutaneous
EVAR.Women comprised 32% of patientswith iliac conduits in
contrast to 17% of those without iliac conduits. Patients with
iliac conduits were older and had a lower body mass index.
Univariable analysis showed patients with open iliac conduits
had a higher incidence of postoperative pneumonia (3.0% vs
1.1%), ventilator dependence (4.8% vs 1.0%), renal failure
(3.0% vs 0.7%), cardiac arrest or myocardial infarction (5.2% vs
1.1%), return to the operating room (9.1% vs 3.7%), major
morbidity (16.0 vs 6.6%), and death (3.0% vs 0.9%). On mul-
tivariable analysis, the use of open iliac conduits was asso-
ciatedwith higher risk of 30-daymortality (odds ratio, 2.7; 95%
conﬁdence interval, 1.2-6.0) and 30-daymajormorbidity (odds
ratio, 2.3; 95% conﬁdence interval, 1.6-3.3).
Conclusions: Patients with open iliac conduits for EVAR are
more likely to be female and have higher postoperative
morbidity and mortality. For patients with complex iliac
artery disease, conduits are a viable alternative after EVAR
to be performed, albeit at an increased risk. These data do
suggest the need for lower-proﬁle grafts and other alter-
native strategies for navigating complex iliac artery disease.Race as a predictor of delay from diagnosis to
endarterectomy in clinically signiﬁcant carotid stenosis
Eric S. Wise, MD, Travis R. Ladner, BA, Jun Song, BA, Susan S.
Eagle, MD, J Mocco, MD, Justine E. Wergin, BS, Kyle M.
Hocking, PhD and Colleen M. Brophy, MD
Objective: Prompt carotid endarterectomy (CEA) in clinically
signiﬁcant carotid stenosis is important in the prevention of
neurologic sequelae. The greatest beneﬁt from surgery is
obtained by prompt revascularization on diagnosis. It has
been demonstrated that black patients both receive CEA
132 Abstractsless frequently than white patients do and experience
worse postoperative outcomes. We sought to test our
hypothesis that black race is an independent risk factor for a
prolonged time from sonographic diagnosis of carotid
stenosis warranting surgery to the day of operation (TDO).
Methods: From 1998 to 2013 at a single institution, 166
CEA patients were retrospectively reviewed using Synthetic
Derivative, a de-identiﬁed electronic medical record. Fac-
tors potentially affecting TDO, including demographics,
preoperative cardiac stress testing, degree of stenosis,
smoking status, and comorbidities, were noted. Multi-
variate analysis was performed on variables that trended
with prolonged TDO on univariate analysis (P < .10) to
determine independent (P < .05) predictors of TDO. Sub-
group analyses were further performed on the symptomatic
and asymptomatic stenosis cohorts.
Results: There were 32 black patients and 134 white
patients studied; the mean TDO was 78  17 days vs 33  3
days, respectively (P < .001). In addition to the need for
preoperative cardiac stress testing, black race was the only
variable that demonstrated a trend with (P < .10) or was an
independent risk factor for (P < .05) prolonged TDO among
all patients (B = 42 days; P < .001) and within the symp-
tomatic (B = 35 days; P = .08) and asymptomatic (B = 35
days; P = .003) cohorts. On Kaplan-Meier analysis, black
patients in each stratum of symptomatology (all, sympto-
matic, and asymptomatic patients) experienced prolonged
TDO (log-rank, P < .03 for all three groups).
Conclusions: Black race is a risk factor for a temporal delay
in CEA for carotid stenosis. Awareness of this disparity may
help surgeons avoid undesirable delays in operation for
their black patients.Outcomes of infrainguinal bypass determined by age in
the Vascular Study Group of New England
Meghan Dermody, MD, MS, Christopher Homsy, MD,
Yuanyuan Zhao, MA, Philip P. Goodney, MD, MS and James
M. Estes, MD, Vascular Study Group of New England
Background: Many believe extremes of age correlate with
poorer outcomes in treatment for lower extremity peripheral
arterial disease (PAD). We hypothesized that the youngest
patients would have signiﬁcantly poorer outcomes compared
with older cohorts due to the precocious nature of their PAD.
Methods: We studied all patients in the Vascular Study
Group of New England database undergoing infrainguinal
bypass for PAD between 2003 and 2013. Age was grouped
by <50 years, 50 to 79 years, and 80 years. Our primary
outcomes were 1-year freedom from a major adverse limb
event (MALE), deﬁned as ipsilateral amputation or need for
secondary intervention, and amputation-free survival. A
second analysis was performed to analyze the subgroup of
patients aged <50 years with critical limb ischemia (CLI),
which included a Cox regression model to determine risk
factors for MALE or death at 1 year.
Results: Of 5265 patients who were treated with infrain-
guinal bypass for PAD, 324 (6.2%) were aged <50 years. Themean age was 44.6 years, and 66.4% were male. The pro-
portion of African Americans was signiﬁcantly higher in the
youngest age group (<50 years: 6.8% vs 50-79 years: 3.5%, P
= .002; vs 80 years: 3.5%, P = .013). More bypasses were
done for claudication than acute limb ischemia in patients
aged <50 years (33.3% vs 11.4%). More vein grafts were
used vs prosthetic (<50 years: 72.1% vs 50-79 years: 65.9%,
P = .024; vs 80 years: 62.6%, P = .002). Fewer concomitant
proximal procedures were performed compared with the
older groups (<50 years: 37.7% vs 50-79 years: 51.1%, P <
.001; vs 80 years: 39.5%, P = .045). More young patients
returned to the operating room within their initial hospital-
ization for early graft thrombosis (<50 years: 5.6% vs 50-79
years: 2.9%, P = .001; vs 80 years: 2.4%, P = .009) and
revision (<50 years: 4.7% vs 50-79 years: 2.2%, P = .012; vs
80 years: 1.4%, P = .002) compared with the older patients.
Overall, MALE-free survival was similar across age groups (P =
.323), as were patency and amputation rates. When consid-
ering only patients with CLI, MALE-free survival in the
youngest patients was again similar (P = .171) but with sig-
niﬁcantly more major amputations at 1 year (P = .022).
Conclusions: For patients aged <50 undergoing infraingui-
nal bypass surgery, this large series demonstrates similar
overall medium-term graft-related outcomes compared
with older cohorts. Further, although the youngest patients
with CLI have similar MALEs, their amputation rates are
higher than in older cohorts.Surgical outcomes of vascular reconstruction in soft tissue
sarcomas of the lower extremities
Kenji Nishinari, MD, PhD, Mariana Krutman, MD, Samuel
Aguiar Junior, MD, PhD, Bruno Soriano Pignataro, MD,
Guilherme Yazbek, MD, PhD, Guilherme Andre Zottele
Bomﬁm, MD, Marcelo Passos Teivelis, MD and Nelson
Wolosker, MD, PhD
Background: Limb-sparing procedures are currently consid-
ered the standard treatment for lower limb soft tissue sar-
coma (STS). Surgical excision combinedwith vascular resection
may be necessary to provide an adequate safetymargin and to
improve the oncologic outcomes. In this scenario, vascular
reconstruction is required to preserve limb function. We
evaluated the long-term patency and survival outcomes of
arterial and venous reconstruction after resecting lower limb
STS in the largest single-center case series to date.
Methods: Between November 1995 and July 2014, 25
patients with lower limb STS and vascular invasion under-
went surgical resection followed by arterial or venous
reconstruction. Patients were followed up at regular out-
patient visits, at which clinical examinations and duplex
ultrasound mapping were performed to assess graft patency.
Results: A total of 44 revascularization procedures were
performed. The median follow-up time for the arterial and
venous groups combined was 25.2 months (range, 0.26-
225.6 months). The 5-year survival probability was 42.1%.
The graft occlusion rate was signiﬁcantly higher after
reconstruction with synthetic grafts than after
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The occlusion rate was not signiﬁcantly different between
arterial reconstruction and venous reconstruction (P > .05).
Conclusions: Arterial and venous reconstruction is feasible
after surgical resection of lower limb STS. Vascular recon-
struction provides favorable long-term patency outcomes and
low complication rates, allowing limb preservation and dis-
ease control in a select group of patients. Vascular recon-
struction using venous grafts had a signiﬁcantly higher patency
rate than reconstruction with artiﬁcial venous substitutes.Preoperative b-blockers do not improve cardiac outcomes
after major elective vascular surgery and may be harmful
Salvatore Scali, MD, Virendra Patel, MD, MPH, Daniel Neal,
MS, Daniel Bertges, MD, Karen Ho, MD, Jens-Eldrup
Jorgensen, MD, Jack Cronenwett, MD and Adam Beck, MD
Objective: Routine initiation b-blocker medications before
vascular surgery is controversial due to conﬂicting data. The
purpose of this analysis was to determine whether prophy-
lactic use of b-blockers beforemajor elective vascular surgery
decreased postoperative cardiac events or mortality.
Methods: The Society for Vascular Surgery Vascular Quality
Initiative (SVS-VQI) data set was used to perform a retro-
spective cohort analysis of infrainguinal lower extremity
bypass (LEB), aortofemoral bypass (AFB), and open
abdominal aortic aneurysm (AAA) repair patients. Chronic
(>30 days preoperatively) b-blocker patients were exclu-
ded, and comparisons were made between preoperative (0-
30 day) and no b-blocker groups. Patients were risk strati-
ﬁed using a novel prediction tool derived speciﬁcally from
the SVS-VQI data set. Propensity-matched pairs and inter-
procedural speciﬁc risk stratiﬁcation comparisons were
performed. End points included in-hospital major adversecardiac events (MACEs), including myocardial infarction (MI;
deﬁned as new ST or T wave electrocardiographic changes,
troponin elevation, or documentation by echocardiogram or
other imaging modality), dysrhythmia, and congestive heart
failure, and 30-day mortality.
Results: The study analyzed 13,291 patients (LEB, 68% [n =
9047]; AFB, 11% [n = 1474]; and open AAA, 21% [n =
2770]); of these, 67.7% (n = 8999) were receiving b-
blockers at time of their index procedure. Speciﬁcally,
13.2% (n = 1753) were identiﬁed to have been started on a
preoperative b-blocker, 54.5% (n = 7426) were on chronic
b-blockers, and 32.3% (n = 4286) were on no preoperative
b-blockers. Among the three procedures, patients had sig-
niﬁcant demographic and comorbidity differences and thus
were not combined. A 1:1 propensity-matched pairs anal-
ysis (1459 pairs) revealed higher rates of postoperative MI
with preoperative b-blockers (preoperative b-blocker rela-
tive risk, 1.65; 95% conﬁdence interval, 1.02-2.68; P = .05 vs
no b-blocker), with no difference in dysrhythmia, con-
gestive heart failure, or 30-day mortality. When stratiﬁed
into low-risk, medium-risk, and high-risk groups within each
procedure, all groups of preoperative b-blocker patients
had no difference or higher rates of MACEs and 30-day
mortality, with the exception of high-risk open AAA
patients, who had a lower rate of MI (odds ratio, 0.35; 95%
conﬁdence interval, 011-0.87; P = .04).
Conclusions: Exclusive of high-risk open AAA patients, pre-
operative b-blockers did not decrease rates of MACEs or
mortality after LEB, AFB, or open AAA. Importantly, expo-
sure to prophylactic preoperative b-blockers increased the
rates of some adverse events in several subgroups. Given
these data, the SVS-VQI cannot support routine initiation of
preoperative b-blockers before major elective vascular sur-
gery in most patients.Selected Abstracts from the Journal of Vascular Surgery: Venous and
Lymphatic DisordersA RIETE registry analysis of recurrent thromboembolism
and hemorrhage in patients with catheter-related
thrombosis
Lisa Baumann Kreuziger, MD, MS, Lauren Cote, RN, BSN,
Peter Verhamme, MD, PhD, Steven Greenberg, MD, Joseph
Caprini, MD, MS, Francisco José Muñoz, MD, Reina Valle,
MD, PhD and Manuel Monreal Bosch, MD, PhD, for the
RIETE Investigators
Background: Few studies have investigated the treatment
and the outcomes of patients with catheter-related
thrombosis (CRT).
Methods: The RIETE registry (Registro Informatizado de
Enfermedad TromboEmbólica [Computerized Registry of
Patients with Venous Thromboembolism]) is a prospective
international registry of consecutive patients with objec-
tively conﬁrmed venous thromboembolism (VTE). Weanalyzed the characteristics, treatment, and outcomes of
patients with CRT.
Results: Of 558 patients with CRT, 45 (8%) presented with a
pulmonary embolism (PE) concomitantly. More patients had
central line-associated thrombosis compared with port sys-
tems, but catheter type did not inﬂuence the risk of presenting
with a PE. Patients with only CRT were more often prescribed
low-molecular-weight heparin for the duration of their anti-
coagulant treatment compared with patients presenting with
concomitant PE. VTE recurrences and major bleeding events
occurred frequently during treatment with anticoagulation (7
per 100 patient-years and 8.9 per 100 patient years, respec-
tively). The rates of fatal PE recurrences (1.85 per 100 patient-
years) and fatal bleeding (2.32 per 100 patient-years) were
similar. Patients with an additional transient risk factor for VTE
had the lowest risk for VTE recurrences (odds ratio [OR], 0.07;
134 Abstracts90% conﬁdence interval [CI], 0.01-0.45) compared with
patientswith CRT and no additional transient risk factors. PE at
presentation increased the risk of recurrent thrombosis by 2.4
times. Renal insufﬁciency was also an independent predictor
of recurrent thrombosis (OR, 3.93; 90% CI, 2.0-7.7). The odds
of recurrent thrombosis was decreased by 77% in patients
who received anticoagulation therapy for>90 days compared
with patients with a shorter treatment (OR, 0.23; 90% CI,
0.1-0.56).
Conclusions: Concomitant PE occurs less frequently in CRT
than lower extremity deep venous thrombosis, but it is
associated with a worse outcome. CRT occurs in high-risk
patients, and duration of anticoagulation must be pre-
dicated on balancing these risks.A study of increase in leg volume during complex physical
therapy for leg lymphedema using subcutaneous tissue
ultrasonography
Kotaro Suehiro, MD, Noriyasu Morikage, MD, Masanori
Murakami, MD, Osamu Yamashita, MD, Takasuke Harada,
MD, Koshiro Ueda, MD, Makoto Samura, MD and Kimikazu
Hamano, MD
Objective: The purpose of this study was to discuss the
mode of increase in leg volume during complex physical
therapy (CPT) for lymphedema using subcutaneous tissue
ultrasonography.
Methods: Thirty-eight patients (51 legs) with secondary
lymphedema who were treated by CPT for longer than 2years (3.0  0.8 years) at our clinic were studied. The leg
circumferences were measured at every visit. Subcutaneous
tissue ultrasonography was performed at the initial and
latest visits.
Results: The overall change in leg volume was 284  915
(range, 4588 to 1139) mL. Among them, the increase in
leg volume was found in 18 legs; of those, 9 (1 in stage I, 7
in stage II, 1 in stage III) were adherent to hosiery use. In
the legs whose average volume was decreased (group A, n =
33; mean, 821 [4588 to 19] mL), the circumference
had decreased in all the leg levels. However, in the legs
whose average volumes had increased (group B, n = 18;
mean, +449 [18-1139] mL), the circumference had increased
in the thigh but remained unchanged or even decreased in
the lower leg. In group B, subcutaneous thickness (SCT),
subcutaneous echogenicity (SEG), and subcutaneous echo-
free space (SEFS), assessed by ultrasonography, were found
to have increased particularly in the lower medial thigh
compared with those in group A (SCT change: group A, 1.5
 5.9 cm vs group B, 3.7  5.4 cm [P < .05]; SEG grade
change: group A, 0.3  0.7 vs group B, 0.3  0.7 [P < .05];
SEFS grade change: group A, 0.1  0.7 vs group B, 0.4 
0.6 [P < .05]), whereas these remained unchanged or even
decreased in the lower leg.
Conclusions: Increase in leg volume during CPT might not
be caused simply by noncompliance to hosiery use and
seemed closely related to the increase in thigh circum-
ferences, particularly the lower thigh, in which SCT, SEG,
and SEFS were increased.
